Idexx Laboratories (IDXX) Cost of Revenue (2009 - 2026)

Idexx Laboratories' Cost of Revenue history runs 18 years deep, the most recent figure standing at $175.2 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 53.27% year-over-year to $175.2 million; the TTM figure through Mar 2026 stood at $925.3 million (down 12.36% YoY), while the FY2025 annual figure was $643.5 million, up 9.35% from the prior year.
• Cost of Revenue was $175.2 million for Q1 2026 at Idexx Laboratories, up from $167.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $421.9 million in Q3 2025 to a low of -$529.5 million in Q4 2023.
• Historically, Cost of Revenue has averaged $176.2 million across 5 years, with a median of $150.1 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue jumped 191.11% in 2022, then plunged 501.32% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $131.9 million in 2022, then slumped by 501.32% to -$529.5 million in 2023, then jumped by 128.35% to $150.1 million in 2024, then advanced by 11.29% to $167.1 million in 2025, then gained by 4.9% to $175.2 million in 2026.
• The last three Cost of Revenue figures came in at $175.2 million (Q1 2026), $167.1 million (Q4 2025), and $421.9 million (Q3 2025), per Business Quant data.